Because most of the short isoforms are derived from the full-length CUX1 transcript, RNAi approach is not able to specifically knock down indicated isoforms, which makes RNAi not suitable to determine the roles of full-length CUX1 and its isoforms in tumor progression. The gene discussed is CUX1; the disease is neoplasm.